Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.

MLA

Ganschow, Rainer, et al. “Everolimus and Reduced Calcineurin Inhibitor Therapy in Pediatric Liver Transplant Recipients: Results from a Multicenter, Prospective Study.” Pediatric Transplantation, vol. 21, no. 7, Nov. 2017. EBSCOhost, https://doi.org/10.1111/petr.13024.

APA

Ganschow, R., Ericzon, B.-G., Dhawan, A., Sharif, K., Martzloff, E.-D., Rauer, B., Ng, J., & Lopez, P. (2017). Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study. Pediatric Transplantation, 21(7). https://doi.org/10.1111/petr.13024

Chicago

Ganschow, Rainer, Bo-Goran Ericzon, Anil Dhawan, Khalid Sharif, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, and Patricia Lopez. 2017. “Everolimus and Reduced Calcineurin Inhibitor Therapy in Pediatric Liver Transplant Recipients: Results from a Multicenter, Prospective Study.” Pediatric Transplantation 21 (7). doi:10.1111/petr.13024.